ScreenerHero

CLVRClever Leaves Holdings Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · cleverleaves.com
0.0001USD0.00%Mkt Cap: 175 $P/E: —

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, ma…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.19BUSDP/E 23.7
TAK
Takeda Pharmaceutical Co. Ltd.
$58.06BUSD
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.98BUSDP/E 20.4
TEVA
Teva Pharmaceutical Industries Limited
$43.51BUSDP/E 62.2
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
ZTS
Zoetis Inc.
$32.12BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.01BUSDP/E 18.4
VTRS
Viatris, Inc.
$18.75BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.34BUSDP/E 117.3
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
NBIX
Neurocrine Biosciences, Inc.
$15.51BUSDP/E 22.3
ELAN
Elanco Animal Health Incorporat
$11.98BUSD
RDY
Dr. Reddy's Laboratories Ltd
$10.15BUSDP/E 29.7
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
ALKS
Alkermes plc
$8.11BUSDP/E 127.2
HIMS
Hims & Hers Health, Inc.
$7.88BUSD
LNTH
Lantheus Holdings Inc
$6.53BUSDP/E 23.9
AMRX
Amneal Pharmaceuticals, Inc. Class A
$6.24BUSDP/E 37.3
LQDA
Liquidia Corporation
$6.14BUSDP/E 49.0
KNSA
Kiniksa Pharmaceuticals, Ltd.
$6.08BUSDP/E 79.8

Key Statistics

Company
Market Cap175 $
Enterprise Value-4.74M $
Revenue (TTM)17.42M $
Gross Profit6.56M $
Net Income (TTM)-17.90M $
Revenue/Share11.11 USD
Last Price0.0001 USD
Fiscal Year EndDec 2023
MR QuarterDec 2023
Employees296
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.36
EV/Revenue-0.27
P/S0.00
P/B0.00
EPS (TTM)-2.11
EPS (Forward)-6.60
52W Range
0.00010% of range0.5000
52W High0.5000 USD
52W Low0.0001 USD
Profitability
Gross Margin37.64%
Oper. Margin-105.91%
EBITDA Margin-75.90%
Profit Margin-102.77%
ROE-73.91%
ROA-57.29%
Growth
Revenue Growth5.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.51M $
CapEx (TTM)31.00K $
FCF Margin-12.90%
FCF Yield-1283428.57%
Net Debt-4.74M $
Net Debt/EBITDA0.36
Balance Sheet
Debt/Equity0.09
Current Ratio2.40
Quick Ratio1.53
Book Value/Sh14.02 USD
Cash/Share3.893 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateAug 25, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.75M
Float1.43M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.5d
Short % Float2.17%
Short % Out.2.02%
Shares Short35.50K
Short (prev mo.)20.09K
Technical
SMA 500.0001 (-20.6%)
SMA 2000.0015 (-93.2%)
Beta1062.44
S&P 52W Chg18.16%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)17.5
MACD-0.0000
MACD Signal-0.0000
MACD Hist.+0.0000
BB Upper0.0001 USD
BB Middle0.0001 USD
BB Lower0.0001 USD
BB Width0.00%
ATR (14)0.0000 USD
Vol Ratio (20d)—